Martin R Stockler (Martin Stockler)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Diffusion Weighted

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Patient related outcome measures

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Peter S Grimison, Antony Mersiades, Adrienne Kirby, Annette Tognela, Ian N Olver, Rachael Lisa Morton, Paul Haber, Anna Walsh, Yvonne Lee, Ehtesham Abdi, Stephen Della-Fiorentina, Morteza Aghmesheh, Peter Fox, Karen Briscoe, Jasotha Sanmugarajah, Gavin Marx, Ganessan Kichenadasse, Helen Wheeler, Matthew Chan, Jenny Shannon, Craig Gedye, Stephen D Begbie, R John Simes, Martin R Stockler
Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Rachel Campbell, Madeleine T King, Martin R Stockler, Yeh Chen Lee, Felicia T Roncolato, Michael L Friedlander
Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice. Patient related outcome measures 14 (2023)
Ann Livingstone, Kirsten Howard, Alexander M Menzies, Georgina V Long, Martin R Stockler, Rachael Lisa Morton
Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma-A Discrete Choice Experiment. The patient (2023)
Ciara Conduit, Jeremy H Lewin, Andrew Weickhardt, James Lynam, Shirley Wong, Peter S Grimison, Shomik Sengupta, Ganes Pranavan, Francis Parnis, Patricia Bastick, David Campbell, Aaron Richard Hansen, Matt Leonard, Margaret McJannett, Martin R Stockler, Peter Gibbs, Guy Toner, Ian D Davis, Ben Tran, Anna Kuchel
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations. JCO oncology practice (2023)
Rachel Campbell, Madeleine T King, Martin R Stockler, Yeh Chen Lee, Felicia T Roncolato, Michael L Friedlander
Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice. Patient related outcome measures 14 (2023)
Sandra Christine Hayes, Andreas Obermair, Linda Mileshkin, Alison Davis, Louisa G Gordon, Elizabeth Eakin, Monika Janda, Vanessa L Beesley, Elizabeth H Barnes, Rosalind Renee Spence, Carolina Sandler, Tamara Jones, Dimitrios Vagenas, Penny Webb, John Andrews, Alison Brand, Yeh Chen Lee, Michael Friedlander, Kate Pumpa, Helene O'Neille, Merran Williams, null null, Martin R Stockler, null null
Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial. BMJ open 13 (4) (2023)
Bhavna Oza, Tim Eisen, Eleni Frangou, Grant D Stewart, Axel Bex, Alastair W S Ritchie, Richard S Kaplan, Benjamin Smith, Ian D Davis, Martin R Stockler, Laurence Albiges, Bernard Escudier, James M G Larkin, Steven Joniau, Barry Hancock, Gregers G Hermann, Joaquim Bellmunt, Mahesh K B Parmar, Patrick Royston, Angela Mary Meade
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (16) (2022)
Martin R Stockler, Andrew J Martin, Haryana M Dhillon, Ian D Davis, Christopher J Sweeney
Reply to L. Marandino et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (19) (2022)
Blossom Mak, Hui Ming Lin, Thy Duong, Kate L Mahon, Anthony M Joshua, Martin R Stockler, Howard Gurney, Francis Parnis, Alison Zhang, Tahlia Scheinberg, Gary Wittert, Lisa M Butler, David Sullivan, Andrew J Hoy, Peter J Meikle, Lisa G Horvath
Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin. Cancers 14 (19) (2022)
Ann Livingstone, Donna Milne, Kathy L Flitcroft, Danielle Marie Muscat, Alexander M Menzies, Kirsten Howard, Martin R Stockler, Rachael Lisa Morton
Should I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners. The patient 14 (5) (2021)
Orlando Rincones, Allan 'Ben' Smith, Sayeda Naher, Rebecca Mercieca-Bebber, Martin R Stockler
An Updated Systematic Review of Quantitative Studies Assessing Anxiety, Depression, Fear of Cancer Recurrence or Psychological Distress in Testicular Cancer Survivors. Cancer management and research 13 (2021)
Rhonda Farrell, Michael J Burling, Yeh Chen Lee, Selvan Pather, Kristy P Robledo, Rebecca Mercieca-Bebber, Martin R Stockler, null null
Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020). Journal of gynecologic oncology (2021)
Ann Livingstone, Kathy L Flitcroft, Martin R Stockler, Kirsten Howard, Georgina V Long, Matteo S Carlino, Alexander M Menzies, Rachael Lisa Morton
Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews. BMC cancer 21 (1) (2021)
Rebecca Mercieca-Bebber, Sayeda Kamrun Naher, Orlando Rincones, Allan 'Ben' Smith, Martin R Stockler
Patient-Reported Outcomes Associated with Treatments for Testicular Cancer: A Systematic Review. Patient related outcome measures 12 (2021)
Martin R Stockler, Andrew J Martin, Ian D Davis, Haryana M Dhillon, Stephen D Begbie, Kim N Chi, Simon Chowdhury, Xanthi Coskinas, Mark Frydenberg, Wendy E Hague, Lisa G Horvath, Anthony M Joshua, Nicola J Lawrence, Gavin M Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott A North, Francis Parnis, Wendy R Parulekar, David W Pook, M Neil Reaume, Shahneen Sandhu, Alvin Tan, Thean Hsiang Tan, Alastair Thomson, Francisco Emilio Vera-Badillo, Scott G Williams, Diana G Winter, Sonia Yip, Alison Y Zhang, Robert R Zielinski, Christopher J Sweeney, null null
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (8) (2021)
Prunella L Blinman, Andrew James Martin, Michael Jefford, David Goldstein, David Boadle, Michelle Morris, Niall Tebbutt, Christine Aiken, Andrea Harkin, Eva Segelov, Andrew Haydon, Timothy J Iveson, Martin R Stockler
Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer. JNCI cancer spectrum 5 (1) (2020)